
One Health: Viola Polyphenols
Concept Overview
Viola Polyphenols, derived from proprietary lettuce varieties, are plant-based bioactives with anti-inflammatory, antioxidant, antiviral, and antimicrobial properties. They align with the One Health approach by bridging human, animal, and environmental health, reducing reliance on synthetic drugs and antibiotics.

Market Opportunity
-
Global Human Health & Wellness: $3.3T by 2030 (CAGR ~9%).
-
Animal Nutrition Market: $750B by 2030 (CAGR ~6–7%).
-
Functional Food Ingredients: $120B by 2030 (CAGR ~8%).
-
Pet Care & Nutrition: $150B by 2030 (CAGR ~7–8%).

Business Models
-
B2B Ingredient Supply – Licensing and bulk sales of Viola Polyphenols to nutraceutical, feed, and cosmetic companies.
-
B2C Products – Own branded line: capsules, powders, functional beverages, pet supplements, eco-friendly cat litter (tofu-polyphenol blend).
-
Licensing & Partnerships – Strategic partnerships with global feed companies, pharma, and consumer wellness brands.
-
Digital Health Ecosystem – Integration with AI-driven therapeutic monitoring (Pulse Mesh Health platform).

Core Business Applications
A. Human Health
-
Functional Food & Supplements: Capsules, powders, beverages targeting stress relief, sleep aid, metabolic balance, and anti-aging.
-
Medical Nutrition: Support for diabetes, cardiovascular health, immune modulation.
-
Topical & Beauty: Anti-inflammatory and antioxidant applications in skin care and holistic beauty.
-
Digital Therapy Integration: Combined with AI-driven non-invasive acupuncture and monitoring solutions for sleep and stress.
B. Animal Health (Veterinary & Feed Additives)
-
Poultry, Swine, and Aquaculture: Polyphenol-based feed additives for disease prevention (e.g., bird flu, ASF, viral shrimp diseases) and growth performance.
-
Pet Nutrition: Anti-inflammatory and gut-health–supporting ingredients in premium pet food and supplements.
-
Antibiotic Alternative: Natural antimicrobial solution that reduces antimicrobial resistance (AMR) risk.
C. Environmental & One Health Impact
-
Sustainable Agriculture: Waste-to-value cycle through lettuce cultivation and eco-friendly extraction.
-
Reduced Antibiotic Pollution: Limiting antibiotic use in livestock and aquaculture decreases environmental contamination.
-
Zoonotic Disease Control: Prevention of cross-species viral transmission reduces pandemic risk.

Competitive Edge
-
Next-gen CBD Alternative: Higher bioavailability, stability, and broader health benefits.
-
ESG Alignment: Sustainable, plant-based, antibiotic-free solution.
-
Patented IP: Proprietary extraction technology and polyphenol formulations.
-
One Health Strategy: Positioned at the intersection of human, animal, and environmental health.

Business Development Milestones
-
B2B Ingredient Supply – Licensing and bulk sales of Viola Polyphenols to nutraceutical, feed, and cosmetic companies.
-
B2C Products – Own branded line: capsules, powders, functional beverages, pet supplements, eco-friendly cat litter (tofu-polyphenol blend).
-
Licensing & Partnerships – Strategic partnerships with global feed companies, pharma, and consumer wellness brands.
-
Digital Health Ecosystem – Integration with AI-driven therapeutic monitoring (Pulse Mesh Health platform).

Advantage vs CBD
Feature | CBD (Hemp) | Viola Polyphenols (Lettuce) |
|---|---|---|
Cost | Expensive, volatile | Scalable, cost-efficient |
Bioavailability | Low (<10%) | Enhanced absorption |
Efficacy | Mixed, inconsistent | Strong antioxidant, anti-inflammatory |
Safety | THC contamination risk | Non-psychoactive, safe |
Regulatory | Restricted, unclear FDA | GRAS/FDA food ingredient pathway |
